Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s461969 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Yi Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Pharmaceutical University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Celecoxib, Hyaluronic Acid, Biological Availability, Drug Carriers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
- The Innovation Team for Integrating Pharmacy with Entrepreneurship, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
- Guangdong Laboratory Animals Monitoring Institute, Guangdong Provincial Key Laboratory of Laboratory Animals, Guangzhou, People's Republic of China.
- Analytical and Testing Center of Guangzhou University, Guangzhou, People's Republic of China.
ORCID-Profile: Sa Huang, Junfeng Ban
Zitieren
APA
Zhu, Y., Chen, M., Yang, C., Lu, G., Huang, S., Chen, M., Wang, Y., & Ban, J. (2024). Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s461969
Vancouver
Zhu Y, Chen M, Yang C, Lu G, Huang S, Chen M, et al. Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s461969
BibTeX
@article{Zhu2024,
author = {Zhu, Yi and Chen, Meiling and Yang, Chuangzan and Lu, Geng and Huang, Sa and Chen, Meili and Wang, Yufei and Ban, Junfeng},
title = {Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s461969}
}
EUVIMED